| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/12/2008 | US7329767 Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof |
| 02/12/2008 | US7329731 Soluble T cell receptor |
| 02/12/2008 | US7329721 Maleamic acid polymer derivatives and their bioconjugates |
| 02/12/2008 | US7329638 Drug delivery compositions |
| 02/12/2008 | US7329543 Red blood cells loaded with S-nitrosothiol and uses therefor |
| 02/12/2008 | US7329516 Methods for increasing protein polyethylene glycol (PEG) conjugation |
| 02/12/2008 | US7329507 Linking oligopeptide to a stabilizing group, linking the oligopeptide to a therapeutic agent, testing if the conjugate is cleavable by Thimet oligopeptidase |
| 02/12/2008 | CA2488011C External preparations for treating dermatitis |
| 02/12/2008 | CA2427583C Inhalable formulation of a solution containing a tiotropium salt |
| 02/12/2008 | CA2416823C Antimycotic nail varnish composition |
| 02/12/2008 | CA2411577C Stabiliser for radiopharmaceuticals |
| 02/12/2008 | CA2402405C Compositions containing alpha-2-adrenergic agonist components |
| 02/12/2008 | CA2374003C Improved cellular uptake of bioactive agents |
| 02/12/2008 | CA2373473C Electrolyte gels for maintaining hydration and rehydration |
| 02/12/2008 | CA2346132C Antibacterial agents and process for producing the same |
| 02/12/2008 | CA2341063C Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder |
| 02/12/2008 | CA2332922C Enteric coated pharmaceutical composition and method of manufacturing |
| 02/12/2008 | CA2317048C Self-foaming cleansing systems comprising an acid component and an alkali metal bicarbonate component |
| 02/12/2008 | CA2315261C Oral pharmaceutical extended release dosage form |
| 02/12/2008 | CA2303432C Modulation of drug loading in multivesicular liposomes |
| 02/12/2008 | CA2289260C Controlled release of drugs delivered by sublingual or buccal administration |
| 02/12/2008 | CA2208206C Composition for treating tumors comprising lactose and a saccharide conjugate of a cytotoxic phenolic compound |
| 02/12/2008 | CA2202137C Composition, device and method for enhanced electrotransport agent delivery |
| 02/12/2008 | CA2174236C Superoxide dismutase and mimetics thereof |
| 02/12/2008 | CA2151957C Aqueous pharmaceutical preparations of g-csf which are stable in storage |
| 02/12/2008 | CA2151732C Stable lyophilized pharmaceutical preparations of g-csf |
| 02/12/2008 | CA2116500C Canine coronavirus vaccine from feline enteric coronavirus |
| 02/12/2008 | CA2104699C Sustained release drug delivery devices |
| 02/07/2008 | WO2008016729A1 Compositions for intranasal delivery of human insulin and uses thereof |
| 02/07/2008 | WO2008016165A2 Liquid preparation |
| 02/07/2008 | WO2008016163A1 Crosslinked gelatin gel multilayered structure, carrier for bioactive factor, preparation for release of bioactive factor, and their production methods |
| 02/07/2008 | WO2008016077A1 Adhesive preparation |
| 02/07/2008 | WO2008016016A1 Aqueous liquid preparation containing amide compound |
| 02/07/2008 | WO2008015959A1 Pharmaceutical composition improved in absorption of pharmacologically active substance |
| 02/07/2008 | WO2008015695A2 Inclusion complex of olopatadine and cyclodextrin |
| 02/07/2008 | WO2008015583A1 Exhaust manifolds including heat shield assemblies |
| 02/07/2008 | WO2008015539A2 Topical preparation containing sirolimus for treating inflammatory skin deseases |
| 02/07/2008 | WO2008015484A1 Oily preparation for the alternative therapy of the human musculoskeletal system |
| 02/07/2008 | WO2008015415A2 Asymmetric fluoro-substituted polymethine dyes |
| 02/07/2008 | WO2008014686A1 Formulation containing low molecular heparin for intraarticular injection |
| 02/07/2008 | WO2008014685A1 Formulation containing trehalose for intraarticular injection |
| 02/07/2008 | WO2008014612A1 Fusion proteins and methods for modulation of immune response |
| 02/07/2008 | WO2008014610A1 Drug delivery compositions and methods of forming and using same |
| 02/07/2008 | WO2007149560A3 Fermentation and purification of actinomadura chromoprotein and related species |
| 02/07/2008 | WO2007121302A3 Antioxidant compositions for reducing odor in warming lubricant compositions |
| 02/07/2008 | WO2007092465A3 Topical delivery compositions |
| 02/07/2008 | WO2006116742A3 Fluorescent nanoparticles conjugated to antibodies via a peg linker |
| 02/07/2008 | WO2006044063A3 Transepithelial delivery of peptides with incretin hormone activities |
| 02/07/2008 | WO2005117999A3 Imaging and therapeutic agents targeting proteins expressed on endothelial cell surface |
| 02/07/2008 | US20080033204 Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino] butanoate |
| 02/07/2008 | US20080033156 Short interfering nucleic acid (siNA) molecule and a polyamine compound having guanidinium, amine, or histidyl end groups and optionally containing polyether groups; biodrug delivery |
| 02/07/2008 | US20080033105 Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof |
| 02/07/2008 | US20080033059 Enteric Coating Compositions |
| 02/07/2008 | US20080033058 Personal care compositions that deposit hydrophilic benefit agents |
| 02/07/2008 | US20080033027 Drug combination pharmaceutical compositions and methods for using them |
| 02/07/2008 | US20080033009 Solid Pharmaceutical Formulation |
| 02/07/2008 | US20080032384 Pharmaceutical Preparation Containing Bacterial Cell Wall Skeleton |
| 02/07/2008 | US20080032350 Alpha-isomaltosylglucosaccharide-forming enzyme, process and uses of the same |
| 02/07/2008 | US20080032020 Center-filled chewing gum containing a deliverable form of calcium |
| 02/07/2008 | US20080031970 Method of Promoting Natural Bypass |
| 02/07/2008 | US20080031965 Oral Preparations and Process for Production Thereof |
| 02/07/2008 | US20080031963 Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
| 02/07/2008 | US20080031952 Nucleic Acid Comprising a Sequence Encoding a Modified Glutenin Polypeptide |
| 02/07/2008 | US20080031946 Low-Dose Tablets Having a Network of Polymers |
| 02/07/2008 | US20080031936 Immunostimulatory nucleic acid molecules |
| 02/07/2008 | US20080031927 Solid oral dosage vitamin and mineral compositions |
| 02/07/2008 | US20080031925 Compositions and Methods to Lower Glycohemoglobin Levels |
| 02/07/2008 | US20080031864 PEG-Urate Oxidase Conjugates and Use Thereof |
| 02/07/2008 | US20080031853 treating Hepatitis-C virus; covalently attached to a nonpeptide polyoxyethylene glycol moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells; drugs/polymer conjugates/ as viricides |
| 02/07/2008 | US20080031848 Preparation of Polymer Conjugates of Therapeutic, Agricultural, and Food Additive Compounds |
| 02/07/2008 | US20080031835 Antiinflammatory And Analgesic Preparation For External Use |
| 02/07/2008 | US20080031814 Non-allergenic ingredients and food products |
| 02/07/2008 | US20080031813 Targeted Combination Immunotherapy of Cancer and Infectious Diseases |
| 02/07/2008 | US20080029083 Ejection liquid and ejection method |
| 02/07/2008 | CA2695147A1 Dyes and precursors and conjugates thereof |
| 02/07/2008 | CA2695117A1 Dyes and precursors and conjugates thereof |
| 02/07/2008 | CA2693326A1 Gm-csf and il-15 fusokines and methods for modulation of the immune response |
| 02/07/2008 | CA2660029A1 Compositions for intranasal delivery of human insulin and uses thereof |
| 02/07/2008 | CA2659750A1 Biogenic silica from silica-containing plant material such as rice hulls |
| 02/07/2008 | CA2659687A1 Aqueous liquid preparation containing amide compound |
| 02/07/2008 | CA2659600A1 Drug carriers, their synthesis, and methods of use thereof |
| 02/07/2008 | CA2659391A1 Antibiotic composition |
| 02/07/2008 | CA2659390A1 Liquid preparation |
| 02/07/2008 | CA2652220A1 Adhesive preparation comprising methyl salicylate for percutaneous absorption |
| 02/07/2008 | CA2596153A1 Rimonabant-containing pharmaceutical preparation |
| 02/06/2008 | EP1884507A1 Method for manufacturing glycerine |
| 02/06/2008 | EP1884232A1 Method of producing liposomes containing gas enclosed therein |
| 02/06/2008 | EP1883699A2 Non-viral vector system for transporting nucleic acid into the lungs |
| 02/06/2008 | EP1883698A1 Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen |
| 02/06/2008 | EP1883426A2 Multi-component vitamin and mineral supplement for the optimal absorption of components |
| 02/06/2008 | EP1883396A1 Colonic delivery of adsorbents |
| 02/06/2008 | EP1883390A2 Topical compositions |
| 02/06/2008 | EP1883317A2 Dosage form for oral administration of a vitamin |
| 02/06/2008 | EP1521600B1 Bisacyloxypropylcysteine conjugates and the use thereof |
| 02/06/2008 | CN101119750A Anti-cancer treatment |
| 02/06/2008 | CN101119749A Gastric inhibitory polypeptide (gip) antigen arrays and uses thereof |
| 02/06/2008 | CN101119733A Method for reducing or avoiding adverse effect of steroid compound |
| 02/06/2008 | CN101119730A Ointment |
| 02/06/2008 | CN101119716A External plaster containing flurbiprofen |
| 02/06/2008 | CN101119711A Method of use herbal compositions |